Inhibition of NHE1 with cariporide or ACE with enalapril did not prevent atrial effective refractory period abbreviation or AF inducibility caused by 7-day atrial tachypacing in dogs.
Does cariporide or enalapril prevent longer-term (7-day) atrial tachycardia-induced electrical remodeling in dogs?
Inhibition of NHE1 or ACE does not prevent electrical remodeling induced by 7-day atrial tachycardia in dogs, suggesting different mechanisms from short-term remodeling.
p-value: p=NS
BACKGROUND: Inhibitors of the Na(+)/H(+)-exchanger (NHE1) and of angiotensin-converting enzyme (ACE) have been shown to reduce short-term (<6 h) tachycardia-induced atrial electrical remodeling. The role of NHE1 and ACE in longer-term electrical remodeling, as might occur with persistent AF, has not been studied. METHODS: Dogs were subjected to atrial-tachypacing (400 bpm) for 7 days during treatment with 240 mg/day (standard clinical dose) of the NHE1 inhibitor cariporide (CariL, n=6), 1000 mg/day cariporide (CariH, n=6), 2 mg/kg/day of the ACE inhibitor enalapril (E, n=6), or no-drug controls (n=7). To ensure steady state concentrations at the onset of pacing, treatment began 3 days before the initiation of atrial tachypacing. Results were compared to those of unpaced dogs (n=9). RESULTS: Atrial tachypacing reduced atrial effective refractory period (ERP), e.g. at a basic cycle length of 300 ms from 126+/-4 ms (unpaced, mean+/-S.E.) to 79+/-8 ms (no-drug controls, P<0.001). ERP abbreviation was unchanged by CariL (83+/-8 ms), CariH (80+/-7 ms), or E (76+/-5 ms). Atrial tachypacing increased mean duration of the longest AF episode in each dog (DAF) from 130+/-80 s (unpaced) similarly in all groups: 864+/-364 s, no-drug controls; 609+/-376 s, CariL; 709+/-353 s, CariH; 645+/-365 s, E (P=NS for differences among groups). Sustained AF requiring cardioversion for termination was induced in 0% of unpaced dogs vs. 33% of CariL, 33% of CariH, 33% of E, and 43% of control dogs. AF inducibility by single extrastimuli increased from 4+/-2% in unpaced dogs to 48+/-13% (P<0.01) in no-drug control dogs, an effect not changed by CariL (33+/-14%), CariH (35+/-17%) or E (48+/-16%). CONCLUSIONS: In contrast to short-term (several-hour) atrial tachycardia-induced remodeling, remodeling by 7-day tachycardia is not affected by NHE1 or ACE inhibition. These results support the notion that short-term atrial tachycardia remodeling involves different mechanisms from longer-term remodeling, and urges caution in extrapolating results from studies of short-term remodeling to effects in longer-term remodeling as often occurs clinically.
Kaori Shinagawa (Wed,) conducted a other in Atrial tachycardia-induced remodeling (n=34). Cariporide or Enalapril vs. No-drug controls and unpaced dogs was evaluated on Atrial effective refractory period (ERP) at a basic cycle length of 300 ms (p=NS). Inhibition of NHE1 with cariporide or ACE with enalapril did not prevent atrial effective refractory period abbreviation or AF inducibility caused by 7-day atrial tachypacing in dogs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: